A PLA1-2 punch regulates the Golgi complex

Trends in Cell Biology

Volumn 22, Issue 2, 2012, Pages 116-124

  Bechler, Marie E ^a   De Figueiredo, Paul ^b   Brown, William J ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT PROTEIN 53; PHOSPHOLIPASE A1; PHOSPHOLIPASE A1 GAMMA; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 ALPHA; PHOSPHOLIPASE A2 BETA; UNCLASSIFIED DRUG;

CELL FUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL STRUCTURE; ENDOSOME; GOLGI COMPLEX; HUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHOLIPASES A2; PROTEIN TRANSPORT;

MAMMALIA;

EID: 84856531732     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2011.10.003     Document Type: Review

References (103)

1. Emr S., et al. Journeys through the Golgi - taking stock in a new era. J. Cell Biol. 2009, 187:449-453.
2. Trucco A., et al. Secretory traffic triggers the formation of tubular continuities across Golgi sub-compartments. Nat. Cell Biol. 2004, 6:1071-1081.
3. 2) enzymes in membrane trafficking: mediators of membrane shape and function. Traffic 2003, 4:214-221.
4. 2 activity is required for Golgi complex and trans Golgi network membrane tubulation. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:8642-8647.
5. 2 antagonists. Mol. Biol. Cell 1999, 10:1763-1782.
6. 2 antagonists inhibit constitutive retrograde membrane traffic to the endoplasmic reticulum. Traffic 2000, 1:504-511.
7. 2 activity in membrane tubule formation and TGN trafficking. Traffic 2010, 11:1530-1536.
8. 2 biochemistry. Cardiovasc. Drugs Ther. 2009, 23:49-59.
9. Schaloske R.H., Dennis E.A. The phospholipase A2 superfamily and its group numbering system. Biochim. Biophys. Acta 2006, 1761:1246-1259.
10. 1 with sequence homology to a mammalian Sec23p-interacting protein, p125. J. Biol. Chem. 2002, 277:11329-11335.
11. 2β. J. Biol. Chem. 2005, 280:24576-24583.
12. 2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J. Biol. Chem. 2006, 281:6691-6698.
13. 2 enzymes: classification and characterization. Biochim. Biophys. Acta 2000, 1488:1-19.
14. 2 regulation of arachidonic acid mobilization. FEBS Lett. 2002, 531:2-6.
15. 2 structure/function, mechanism, and signaling. J. Lipid Res. 2009, 50(Suppl.):S237-S242.
16. Zimmerberg J., Kozlov M.M. How proteins produce cellular membrane curvature. Nat. Rev. Mol. Cell Biol. 2006, 7:9-19.
17. Bard F., Malhotra V. The formation of TGN-to-plasma-membrane transport carriers. Annu. Rev. Cell Dev. Biol. 2006, 22:439-455.
18. 2α at the Golgi. Biochimie 2010, 92:620-626.
19. 2 C2 domain specify targeting to Golgi and ER in live cells. Mol. Biol. Cell 2004, 15:371-383.
20. 2-α and cyclooxygenase-2 localize to intracellular membranes of EA.hy.926 endothelial cells that are distinct from the endoplasmic reticulum and the Golgi apparatus. FEBS J. 2005, 272:1278-1290.
21. 2-α mediates endothelial cell proliferation and is inactivated by association with the Golgi apparatus. Mol. Biol. Cell 2005, 16:3800-3809.
22. 2 mediates endothelial cell S phase progression. J. Biol. Chem. 2006, 281:35709-35716.
23. 2α controls the formation of inter-cisternal continuities involved in intra-Golgi transport. PLoS Biol. 2009, 7:e1000194.
24. 2α regulates endothelial cell-cell junction integrity by controlling the trafficking of transmembrane junction proteins. Mol. Biol. Cell 2009, 20:4225-4234.
25. Patterson G.H., et al. Transport through the Golgi apparatus by rapid partitioning within a two-phase membrane system. Cell 2008, 133:1055-1067.
26. 2 and prostaglandin synthesis. J. Biol. Chem. 2009, 284:26897-26907.
27. 2α by sphingomyelin. J. Lipid. Res. 2010, 51:720-728.
28. 2+ signaling. Cell Signal. 2009, 21:440-447.
29. 2 C2 domain using electrostatic potential-modulated spin relaxation magnetic resonance. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:6637-6642.
30. 2. J. Biol. Chem. 2002, 277:23838-23846.
31. Wooten R.E., et al. Novel translocation responses of cytosolic phospholipase A2α fluorescent proteins. Biochim. Biophys. Acta 2008, 1783:1544-1550.
32. 2+ from the Golgi apparatus. Exp. Cell Res. 2010, 316:2071-2086.
33. Pulvirenti T., et al. A traffic-activated Golgi-based signalling circuit coordinates the secretory pathway. Nat. Cell Biol. 2008, 10:912-922.
34. 2 activation by phosphorylation. J. Biol. Chem. 2003, 278:41431-41442.
35. 2. Nature 1997, 390:622-625.
36. 2 in allergic response and parturition. Nature 1997, 390:618-622.
37. 2α deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. J. Clin. Invest. 2008, 118:2121-2131.
38. 2 deficiency. Biochemistry 2011, 50:1731-1738.
39. Adler D.H., et al. The enteropathy of prostaglandin deficiency. J. Gastroenterol. 2009, 44(Suppl. 19):1-7.
40. Hattori M., et al. The catalytic subunit of bovine brain platelet-activating factor acetylhydrolase is a novel type of serine esterase. J. Biol. Chem. 1994, 269:23150-23155.
41. Hattori M., et al. Purification and characterization of bovine brain platelet-activating factor acetylhydrolase. J. Biol. Chem. 1993, 268:18748-18753.
42. Ho Y.S., et al. Probing the substrate specificity of the intracellular brain platelet-activating factor acetylhydrolase. Protein Eng. 1999, 12:693-700.
43. Ho Y.S., et al. Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer. Nature 1997, 385:89-93.
44. Tarricone C., et al. Coupling PAF signaling to dynein regulation: structure of LIS1 in complex with PAF-acetylhydrolase. Neuron 2004, 44:809-821.
45. Arai H., et al. Platelet-activating factor acetylhydrolase (PAF-AH). J. Biochem. (Tokyo) 2002, 131:635-640.
46. McIntyre T.M., et al. The emerging roles of PAF acetylhydrolase. J. Lipid Res. 2009, 50:S255-S259.
47. Koizumi H., et al. Targeted disruption of intracellular type I platelet activating factor-acetylhydrolase catalytic subunits causes severe impairment in spermatogenesis. J. Biol. Chem. 2003, 278:12489-12494.
48. Yan W., et al. Previously uncharacterized roles of platelet-activating factor acetylhydrolase 1b complex in mouse spermatogenesis. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7189-7194.
49. Bechler M.E., et al. The phospholipase complex PAFAH Ib regulates the functional organization of the Golgi complex. J. Cell Biol. 2010, 190:45-53.
50. 2) activity, membrane tubules, and dynein-mediated microtubule transport. Biochem. Biophys. Res. Commun. 2009, 389:473-477.
51. Kato M., Dobyns W.B. Lissencephaly and the molecular basis of neuronal migration. Hum. Mol. Genet. 2003, 12:R89-R96.
52. Yamada M., et al. LIS1 and NDEL1 coordinate the plus-end-directed transport of cytoplasmic dynein. EMBO J. 2008, 27:2471-2483.
53. Vallee R.B., Tsai J.W. The cellular roles of the lissencephaly gene LIS1, and what they tell us about brain development. Genes Dev. 2006, 20:1384-1393.
54. Wynshaw-Boris A., et al. Lissencephaly: mechanistic insights from animal models and potential therapeutic strategies. Semin. Cell Dev. Biol. 2010, 21:823-830.
55. Geuze H.J., et al. Membranes of sorting organelles display lateral heterogeneity in receptor distribution. J. Cell Biol. 1987, 104:1715-1723.
56. Geuze H.J., et al. Intracellular site of asiaologlycoprotein receptor-ligand uncoupling: double-label immunoelectron microscopy during receptor-mediated endocytosis. Cell 1983, 32:277-287.
57. 2 antagonists. J. Biol. Chem. 2001, 276:47361-47370.
58. 2 antagonists inhibit multiple endocytic membrane trafficking pathways. Biochem. Biophys. Res. Commun. 2009, 388:695-699.
59. 2 enzyme complex PAFAH Ib mediates endosomal membrane tubule formation and trafficking. Mol. Biol. Cell 2011, 22:2348-2359.
60. Manya H., et al. Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase. J. Biol. Chem. 1999, 274:31827-31832.
61. Manya H., et al. Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain. J. Biol. Chem. 1998, 273:18567-18572.
62. Zhang G., et al. The Pafah1b complex interacts with the Reelin receptor VLDLR. PLoS ONE 2007, 2:e252.
63. 2 and their effect on enzyme activity. J. Biol. Chem. 1998, 273:207-214.
64. 2 from macrophage-like P388D1 cells. Isolation and characterization. J. Biol. Chem. 1994, 269:9227-9233.
65. 2 β or γ inhibits the hormone-induced differentiation of 3T3-L1 preadipocytes. J. Biol. Chem. 2004, 279:21740-21748.
66. 2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells. J. Biol. Chem 1999, 274:13915-13927.
67. 2. Neurology 2008, 71:1402-1409.
68. 2, is mutated in neurodegenerative disorders with high brain iron. Nat. Genet. 2006, 38:752-754.
69. 2 in cell growth and signaling. Biochem. Pharmacol. 2008, 76:1059-1067.
70. 2 regulate morphology and intraorganellar traffic in the endoplasmic reticulum-Golgi intermediate compartment. Mol. Biol. Cell 2010, 21:4130-4140.
71. Appenzeller-Herzog C., Hauri H.P. The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function. J. Cell Sci. 2006, 119:2173-2183.
72. Sannerud R., et al. Retrograde traffic in the biosynthetic-secretory route: pathways and machinery. Curr. Opin. Cell Biol. 2003, 15:438-445.
73. Bui Q.T., et al. Large Arf1 guanine nucleotide exchange factors: evolution, domain structure, and roles in membrane trafficking and human disease. Mol. Genet. Genomics 2009, 282:329-350.
74. Volpicelli-Daley L.A., et al. Isoform-selective effects of the depletion of ADP-ribosylation factors 1-5 on membrane traffic. Mol. Biol. Cell 2005, 16:4495-4508.
75. Peyroche A., et al. Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex: involvement of specific residues of the Sec7 domain. Mol. Cell 1999, 3:275-285.
76. Lippincott-Schwartz J., et al. Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell 1990, 60:821-836.
77. Szul T., et al. Dissecting the role of the ARF guanine nucleotide exchange factor GBF1 in Golgi biogenesis and protein trafficking. J. Cell Sci. 2007, 120:3929-3940.
78. 2β movements in response to stimulation with insulin secretagogues in INS-1 cells. Diabetes 2004, 53(Suppl. 1):S186-S189.
79. 2β-null mice. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E217-E229.
80. Gregory A., Hayflick S.J. Genetics of neurodegeneration with brain iron accumulation. Curr. Neurol. Neurosci. Rep. 2011, 11:254-261.
81. Malik I., et al. Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations. Am. J. Pathol. 2008, 172:406-416.
82. 2 deficiency in mice: a model of human neurodegenerative disease. J. Neurosci. 2008, 28:2212-2220.
83. Kurian M.A., et al. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 2008, 70:1623-1629.
84. 2β causes hypercontractility and markedly attenuates endothelium-dependent relaxation to acetylcholine. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H2208-H2220.
85. 1γ) is a novel factor involved in coat protein complex I- and Rab6-independent retrograde transport between the endoplasmic reticulum and the Golgi complex. J. Biol. Chem. 2009, 284:26620-26630.
86. Sato S., et al. Golgi-localized KIAA0725p regulates membrane trafficking from the Golgi apparatus to the plasma membrane in mammalian cells. FEBS Lett. 2010, 584:4389-4395.
87. 1: structure, location and function. Future Lipidol. 2006, 1:687-700.
88. Shimoi W., et al. p125 is localized in endoplasmic reticulum exit sites and involved in their organization. J. Biol. Chem. 2005, 280:10141-10148.
89. Tani K., et al. p125 is a novel mammalian Sec23p-interacting protein with structural similarity to phospholipid-modifying proteins. J. Biol. Chem. 1999, 274:20505-20512.
90. Darchen F., Goud B. Multiple aspects of Rab protein action in the secretory pathway: focus on Rab3 and Rab6. Biochimie 2000, 82:375-384.
91. Yang J.S., et al. COPI acts in both vesicular and tubular transport. Nat. Cell Biol. 2011, 13:996-1003.
92. Schmidt J.A., Brown W.J. Lysophosphatidic acid acyltransferase 3 regulates Golgi complex structure and function. J. Cell Biol. 2009, 186:211-218.
93. Lippincott-Schwartz J., et al. Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 1991, 67:601-616.
94. Wood S.A., Brown W.J. The morphology but not the function of endosomes and lysosomes is altered by brefeldin-A. J. Cell Biol. 1992, 119:273-285.
95. Wood S.A., et al. Brefeldin A causes a microtubule-mediated fusion of the trans-Golgi network and early endosomes. Cell 1991, 67:591-600.
96. Lemmon M.A. Membrane recognition by phospholipid-binding domains. Nat. Rev. Mol. Cell Biol. 2008, 9:99-111.
97. Sato T.K., et al. Location, location, location: membrane targeting directed by PX domains. Science 2001, 294:1881-1885.
98. Bankaitis V.A. The cirque du soleil of Golgi membrane dynamics. J. Cell Biol. 2009, 186:169-171.
99. 2+ sensor for spontaneous neurotransmitter release. Science 2010, 327:1614-1618.
100. Martens S., et al. How synaptotagmin promotes membrane fusion. Science 2007, 316:1205-1208.
101. McMahon H.T., et al. Membrane curvature in synaptic vesicle fusion and beyond. Cell 2010, 140:601-605.
102. Lippincott-Schwartz J. Cytoskeletal proteins and Golgi dynamics. Curr. Opin. Cell Biol. 1998, 10:52-59.
103. Lippincott-Schwartz J., et al. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 1989, 56:801-813.